
Synthetic Biology Market Size, Share, Trends, Industry Analysis Report: By Product (Oligonucleotide/Oligo Pools & Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, and Chassis Organism), Technology, Application, and Region (North Amer
Description
The synthetic biology market size is expected to reach USD 78.16 billion by 2034, according to a new study by Polaris Market Research. The report “Synthetic Biology Market Size, Share, Trends, Industry Analysis Report: By Product (Oligonucleotide/Oligo Pools & Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, and Chassis Organism), Technology, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Synthetic biology is an interdisciplinary field that applies engineering principles to biology, enabling the design and modification of biological systems for various applications, including healthcare, agriculture, and industrial biotechnology. The synthetic biology market growth is attributed to advancements in genome editing, increasing demand for sustainable bio-manufacturing, and the rising adoption of synthetic biology in drug discovery and personalized medicine. Opportunities in bio-based alternatives to petrochemicals, food innovation, and AI-driven biological engineering are further driving the market expansion. Key synthetic biology market trends include the integration of artificial intelligence for optimizing biological processes, regulatory developments to ensure biosecurity, and increasing investments and collaborations across industries. With expanding applications and technological progress, the market is poised for continued development across multiple sectors.
Synthetic Biology Market Report Highlights:
By product, the oligonucleotide/oligo pools & synthetic DNA segment holds the largest share of the synthetic biology market revenue in 2024 due to its critical role in gene synthesis, genome editing, and molecular diagnostics. The enzymes segment is witnessing rapid growth, driven by their increasing applications in DNA synthesis, PCR, and industrial biotechnology.
Based on technology, the genome editing technology segment dominated the synthetic biology market share, primarily due to the widespread adoption of CRISPR-based applications in drug development and agriculture. NGS technology is experiencing significant growth as sequencing costs decrease and demand for high-throughput genetic analysis increases.
Based on application, the healthcare segment holds the largest market share, with applications in gene therapy, synthetic vaccines, and precision medicine driving its dominance. The non-healthcare segment is growing rapidly, fueled by increasing demand for bio-based chemicals, engineered crops, and synthetic biology-driven environmental solutions.
North America holds the largest synthetic biology market share, supported by strong investments, research advancements, and a well-established biotechnology sector. Asia Pacific is the fastest-growing region, driven by expanding biotech infrastructure, increasing government funding, and rising adoption of synthetic biology in healthcare and industrial applications.
Several key players are actively contributing to advancements across various sectors. These include Amyris, Inc.; Bruker Cellular Analysis; BICO Group AB; Codexis, Inc.; Ginkgo Bioworks Holdings, Inc.; GenScript Biotech Corporation; Integrated DNA Technologies, Inc.; Insitro, Inc.; Novozymes A/S; Pivot Bio, Inc.; Twist Bioscience Corporation; Viridos, Inc.; and Zymergen Inc. (Acquired by Ginkgo Bioworks Holdings, Inc.
Polaris Market Research has segmented the synthetic biology market report on the basis of product, technology, application, and region:
By Product Outlook (Revenue – USD Billion, 2020–2034)
Oligonucleotide/Oligo Pools & Synthetic DNA
Enzymes
Cloning Technologies Kits
Xeno-Nucleic Acids
Chassis Organism
By Technology Outlook (Revenue – USD Billion, 2020–2034)
NGS Technology
PCR Technology
Genome Editing Technology
Bioprocessing Technology
Other Technologies
By Application Outlook (Revenue – USD Billion, 2020–2034)
Healthcare
Non-Healthcare
By Regional Outlook (Revenue – USD Billion, 2020–2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Synthetic biology is an interdisciplinary field that applies engineering principles to biology, enabling the design and modification of biological systems for various applications, including healthcare, agriculture, and industrial biotechnology. The synthetic biology market growth is attributed to advancements in genome editing, increasing demand for sustainable bio-manufacturing, and the rising adoption of synthetic biology in drug discovery and personalized medicine. Opportunities in bio-based alternatives to petrochemicals, food innovation, and AI-driven biological engineering are further driving the market expansion. Key synthetic biology market trends include the integration of artificial intelligence for optimizing biological processes, regulatory developments to ensure biosecurity, and increasing investments and collaborations across industries. With expanding applications and technological progress, the market is poised for continued development across multiple sectors.
Synthetic Biology Market Report Highlights:
By product, the oligonucleotide/oligo pools & synthetic DNA segment holds the largest share of the synthetic biology market revenue in 2024 due to its critical role in gene synthesis, genome editing, and molecular diagnostics. The enzymes segment is witnessing rapid growth, driven by their increasing applications in DNA synthesis, PCR, and industrial biotechnology.
Based on technology, the genome editing technology segment dominated the synthetic biology market share, primarily due to the widespread adoption of CRISPR-based applications in drug development and agriculture. NGS technology is experiencing significant growth as sequencing costs decrease and demand for high-throughput genetic analysis increases.
Based on application, the healthcare segment holds the largest market share, with applications in gene therapy, synthetic vaccines, and precision medicine driving its dominance. The non-healthcare segment is growing rapidly, fueled by increasing demand for bio-based chemicals, engineered crops, and synthetic biology-driven environmental solutions.
North America holds the largest synthetic biology market share, supported by strong investments, research advancements, and a well-established biotechnology sector. Asia Pacific is the fastest-growing region, driven by expanding biotech infrastructure, increasing government funding, and rising adoption of synthetic biology in healthcare and industrial applications.
Several key players are actively contributing to advancements across various sectors. These include Amyris, Inc.; Bruker Cellular Analysis; BICO Group AB; Codexis, Inc.; Ginkgo Bioworks Holdings, Inc.; GenScript Biotech Corporation; Integrated DNA Technologies, Inc.; Insitro, Inc.; Novozymes A/S; Pivot Bio, Inc.; Twist Bioscience Corporation; Viridos, Inc.; and Zymergen Inc. (Acquired by Ginkgo Bioworks Holdings, Inc.
Polaris Market Research has segmented the synthetic biology market report on the basis of product, technology, application, and region:
By Product Outlook (Revenue – USD Billion, 2020–2034)
Oligonucleotide/Oligo Pools & Synthetic DNA
Enzymes
Cloning Technologies Kits
Xeno-Nucleic Acids
Chassis Organism
By Technology Outlook (Revenue – USD Billion, 2020–2034)
NGS Technology
PCR Technology
Genome Editing Technology
Bioprocessing Technology
Other Technologies
By Application Outlook (Revenue – USD Billion, 2020–2034)
Healthcare
Non-Healthcare
By Regional Outlook (Revenue – USD Billion, 2020–2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
118 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
- 4. Global Synthetic Biology Market Insights
- 4.1. Synthetic Biology Market – Market Snapshot
- 4.2. Synthetic Biology Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Advancements in gene editing technologies
- 4.2.1.2. Increasing demand for bio-based products
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Ethical and Biosafety Concerns
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Synthetic Biology Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Synthetic Biology Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 5.3. Oligonucleotide/Oligo Pools & Synthetic DNA
- 5.3.1. Global Synthetic Biology Market, by Oligonucleotide/Oligo Pools & Synthetic DNA, by Region, 2020-2034 (USD Billion)
- 5.4. Enzymes
- 5.4.1. Global Synthetic Biology Market, by Enzymes, by Region, 2020-2034 (USD Billion)
- 5.5. Cloning Technologies Kits
- 5.5.1. Global Synthetic Biology Market, by Cloning Technologies Kits, by Region, 2020-2034 (USD Billion)
- 5.6. Xeno-Nucleic Acids
- 5.6.1. Global Synthetic Biology Market, by Xeno-Nucleic Acids, by Region, 2020-2034 (USD Billion)
- 5.7. Chassis Organism
- 5.7.1. Global Synthetic Biology Market, by Chassis Organism, by Region, 2020-2034 (USD Billion)
- 6. Global Synthetic Biology Market, by Technology
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 6.3. NGS Technology
- 6.3.1. Global Synthetic Biology Market, by NGS Technology, by Region, 2020-2034 (USD Billion)
- 6.4. PCR Technology
- 6.4.1. Global Synthetic Biology Market, by PCR Technology, by Region, 2020-2034 (USD Billion)
- 6.5. Genome Editing Technology
- 6.5.1. Global Synthetic Biology Market, by Genome Editing Technology, by Region, 2020-2034 (USD Billion)
- 6.6. Bioprocessing Technology
- 6.6.1. Global Synthetic Biology Market, by Bioprocessing Technology, by Region, 2020-2034 (USD Billion)
- 6.7. Other Technologies
- 6.7.1. Global Synthetic Biology Market, by Other Technologies, by Region, 2020-2034 (USD Billion)
- 7. Global Synthetic Biology Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 7.3. Healthcare
- 7.3.1. Global Synthetic Biology Market, by Healthcare, by Region, 2020-2034 (USD Billion)
- 7.4. Non-Healthcare
- 7.4.1. Global Synthetic Biology Market, by Non-Healthcare, by Region, 2020-2034 (USD Billion)
- 8. Global Synthetic Biology Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Synthetic Biology Market Assessment, By Geography, 2020-2034 (USD Billion)
- 8.3. Synthetic Biology Market – North America
- 8.3.1. North America: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.3.2. North America: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.3.3. North America: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.3.4. Synthetic Biology Market – U.S.
- 8.3.4.1. U.S.: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.3.4.2. U.S.: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.3.4.3. U.S.: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.3.5. Synthetic Biology Market – Canada
- 8.3.5.1. Canada: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.3.5.2. Canada: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.3.5.3. Canada: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.4. Synthetic Biology Market – Europe
- 8.4.1. Europe: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.4.2. Europe: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.4.3. Europe: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.4.4. Synthetic Biology Market – UK
- 8.4.4.1. UK: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.4.4.2. UK: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.4.4.3. UK: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.4.5. Synthetic Biology Market – France
- 8.4.5.1. France: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.4.5.2. France: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.4.5.3. France: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.4.6. Synthetic Biology Market – Germany
- 8.4.6.1. Germany: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.4.6.2. Germany: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.4.6.3. Germany: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.4.7. Synthetic Biology Market – Italy
- 8.4.7.1. Italy: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.4.7.2. Italy: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.4.7.3. Italy: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.4.8. Synthetic Biology Market – Spain
- 8.4.8.1. Spain: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.4.8.2. Spain: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.4.8.3. Spain: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.4.9. Synthetic Biology Market – Netherlands
- 8.4.9.1. Netherlands: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.4.9.2. Netherlands: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.4.9.3. Netherlands: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.4.10. Synthetic Biology Market – Russia
- 8.4.10.1. Russia: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.4.10.2. Russia: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.4.10.3. Russia: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.4.11. Synthetic Biology Market – Rest of Europe
- 8.4.11.1. Rest of Europe: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.4.11.2. Rest of Europe: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.4.11.3. Rest of Europe: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.5. Synthetic Biology Market – Asia Pacific
- 8.5.1. Asia Pacific: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.5.4. Synthetic Biology Market – China
- 8.5.4.1. China: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.5.4.2. China: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.5.4.3. China: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.5.5. Synthetic Biology Market – India
- 8.5.5.1. India: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.5.5.2. India: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.5.5.3. India: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.5.6. Synthetic Biology Market – Malaysia
- 8.5.6.1. Malaysia: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.5.6.2. Malaysia: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.5.6.3. Malaysia: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.5.7. Synthetic Biology Market – Japan
- 8.5.7.1. Japan: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.5.7.2. Japan: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.5.7.3. Japan: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.5.8. Synthetic Biology Market – Indonesia
- 8.5.8.1. Indonesia: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.5.8.2. Indonesia: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.5.8.3. Indonesia: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.5.9. Synthetic Biology Market – South Korea
- 8.5.9.1. South Korea: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.5.9.2. South Korea: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.5.9.3. South Korea: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.5.10. Synthetic Biology Market – Australia
- 8.5.10.1. Australia: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.5.10.2. Australia: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.5.10.3. Australia: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.5.11. Synthetic Biology Market – Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.6. Synthetic Biology Market – Middle East & Africa
- 8.6.1. Middle East & Africa: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.6.4. Synthetic Biology Market – Saudi Arabia
- 8.6.4.1. Saudi Arabia: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.6.5. Synthetic Biology Market – UAE
- 8.6.5.1. UAE: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.6.5.2. UAE: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.6.5.3. UAE: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.6.6. Synthetic Biology Market – Israel
- 8.6.6.1. Israel: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.6.6.2. Israel: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.6.6.3. Israel: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.6.7. Synthetic Biology Market – South Africa
- 8.6.7.1. South Africa: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.6.7.2. South Africa: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.6.7.3. South Africa: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.6.8. Synthetic Biology Market – Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.7. Synthetic Biology Market – Latin America
- 8.7.1. Latin America: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.7.4. Synthetic Biology Market – Mexico
- 8.7.4.1. Mexico: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.7.4.2. Mexico: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.7.4.3. Mexico: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.7.5. Synthetic Biology Market – Brazil
- 8.7.5.1. Brazil: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.7.5.2. Brazil: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.7.5.3. Brazil: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.7.6. Synthetic Biology Market – Argentina
- 8.7.6.1. Argentina: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.7.6.2. Argentina: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.7.6.3. Argentina: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 8.7.7. Synthetic Biology Market – Rest of Latin America
- 8.7.7.1. Rest of Latin America: Synthetic Biology Market, by Product, 2020-2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: Synthetic Biology Market, by Technology, 2020-2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: Synthetic Biology Market, by Application, 2020-2034 (USD Billion)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. Amyris, Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Arzeda Corp.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Bruker Cellular Analysis
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. BICO Group AB
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Codexis, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Ginkgo Bioworks Holdings, Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. GenScript Biotech Corporation
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Integrated DNA Technologies, Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Insitro, Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Novozymes A/S
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.